The AAFP recommends against the use of combined estrogen and progestin for the prevention of chronic conditions in postmenopausal women. (2012)
(Grade: D recommendation)
Grade Definition: http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm
Clinical Consideration: http://www.uspreventiveservicestaskforce.org/uspstf12/menohrt/menohrtfinalrs.htm#consider
Hormone Replacement Therapy
Hormone Replacement Therapy
Hormone Replacement Therapy
The AAFP recommends against the use of estrogen for the prevention of chronic conditions in postmenopausal women who have had a hysterectomy. (2012)
This recommendation applies to postmenopausal women who are considering hormone therapy for the primary prevention of chronic medical conditions. This recommendation does not apply to women younger than age 50 years who have undergone surgical menopause. This recommendation does not consider the use of hormone therapy for the management of menopausal symptoms, such as hot flashes or vaginal dryness.
(Grade: D recommendation)
Grade Definition: http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm
Clinical Consideration: http://www.uspreventiveservicestaskforce.org/uspstf12/menohrt/menohrtfinalrs.htm#consider
This recommendation applies to postmenopausal women who are considering hormone therapy for the primary prevention of chronic medical conditions. This recommendation does not apply to women younger than age 50 years who have undergone surgical menopause. This recommendation does not consider the use of hormone therapy for the management of menopausal symptoms, such as hot flashes or vaginal dryness.
(Grade: D recommendation)
Grade Definition: http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm
Clinical Consideration: http://www.uspreventiveservicestaskforce.org/uspstf12/menohrt/menohrtfinalrs.htm#consider